Retatrutide has emerged as a new pharmaceutical in the fight against obesity. This revolutionary drug, categorized as a dual GLP-1 and GIP receptor agonist, exhibits promising results in clinical trials. By https://adreanajd060693.pointblog.net/tirzepatide-a-promising-new-treatment-for-obesity-82003887